Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre van Damme

Showing results (11-20 of 365) with videos related to

Pageof 37
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 25, 2008
Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in BelgiumJoke Bilcke, Pierre Van Damme, Philippe Beutels
Vaccine|November 22, 2002
Hepatitis B vaccination: how to reach risk groupsGuido François, Johannes Hallauer, Pierre Van Damme
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|April 27, 2002
Immunisation information for parentsDiana Steimle, Robert Aston, Pierre Van Damme
Plos One|June 28, 2013
Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary ReviewBenson Ogunjimi, Pierre Van Damme, Philippe Beutels
Current Opinion in Infectious Diseases|August 22, 2012
Advances in hepatitis immunization (A, B, E): public health policy and novel vaccine deliveryGreet Hendrickx, Alex Vorsters, Pierre Van Damme
Vaccine|October 14, 2008
The global impact of vaccination against hepatitis B: a historical overviewAlessandro R Zanetti, Pierre Van Damme, Daniel Shouval
Human Vaccines & Immunotherapeutics|December 16, 2020
Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidenceChristian Herzog, Koen Van Herck, Pierre Van Damme
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 16, 2019
HPV vaccination: Are we overlooking additional opportunities to control HPV infection and transmission?Alex Vorsters, Pierre Van Damme, F Xavier Bosch
Acta Gastro-Enterologica Belgica|August 1, 2002
Epidemiology of hepatitis C in Belgium: present and futurePierre Van Damme, A Thyssen, Frank Van Loock
Human Vaccines & Immunotherapeutics|February 10, 2015
The use of urine in the follow-up of HPV vaccine trialsAlex Vorsters, Severien Van Keer, Pierre Van Damme
Pageof 37

Showing results (11-20 of 365) with videos related to

Sort By:
Pageof 37
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 25, 2008
Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in BelgiumJoke Bilcke, Pierre Van Damme, Philippe Beutels
Vaccine|November 22, 2002
Hepatitis B vaccination: how to reach risk groupsGuido François, Johannes Hallauer, Pierre Van Damme
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|April 27, 2002
Immunisation information for parentsDiana Steimle, Robert Aston, Pierre Van Damme
Plos One|June 28, 2013
Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary ReviewBenson Ogunjimi, Pierre Van Damme, Philippe Beutels
Current Opinion in Infectious Diseases|August 22, 2012
Advances in hepatitis immunization (A, B, E): public health policy and novel vaccine deliveryGreet Hendrickx, Alex Vorsters, Pierre Van Damme
Vaccine|October 14, 2008
The global impact of vaccination against hepatitis B: a historical overviewAlessandro R Zanetti, Pierre Van Damme, Daniel Shouval
Human Vaccines & Immunotherapeutics|December 16, 2020
Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidenceChristian Herzog, Koen Van Herck, Pierre Van Damme
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 16, 2019
HPV vaccination: Are we overlooking additional opportunities to control HPV infection and transmission?Alex Vorsters, Pierre Van Damme, F Xavier Bosch
Acta Gastro-Enterologica Belgica|August 1, 2002
Epidemiology of hepatitis C in Belgium: present and futurePierre Van Damme, A Thyssen, Frank Van Loock
Human Vaccines & Immunotherapeutics|February 10, 2015
The use of urine in the follow-up of HPV vaccine trialsAlex Vorsters, Severien Van Keer, Pierre Van Damme
Pageof 37